Headed to AACR? Schedule time to connect with us at bd@ozette.com
Ozette in the news.
Read all about what we’ve been up to in our latest news and recent publications.
Ozette announces strategic partnership with Cerba Research.
The partnership brings together the Cerba Research’s global laboratory network and with Ozette’s 48-color spectral cytometry assay and AI-powered analytics platform to deliver reliable high quality data and standardized, end-to-end immune profiling workflows across translational and clinical development programs.
The Insight’s in the Details: Challenges and Opportunities for BioVis Software Tools
BioVis software tools face critical challenges in handling complex analytical workflows and large-scale experimental data, particularly in enabling detailed visual exploration through computational integration, composability, scalability, and bi-directional AI/ML interactions. In this keynote, Fritz Lekschas (Head of Visualization Research) covers how modern software practices and frameworks can address these challenges, illustrated through examples from genomics, single-cell biology, and the broader BioVis community.
The visualization of large-scale single-cell data through heatmaps faces challenges when displaying thousands of samples and phenotypes along with their metadata, primarily due to screen space limitations and perceptual constraints. Devin Lange presents his internship work on a novel visualization technique that leverages data redundancy through intelligent aggregation of similar phenotypes and samples, enabling interactive collapsible heatmaps that can be viewed at multiple levels of detail while maintaining customizability for various use cases.
Ozette announces new partnership with Bloodworks Northwest.
The partnership will allow Bloodworks Northwest subsidiary, Bloodworks Bio, to leverage Ozette’s Lab and proprietary immune cell population discovery and annotation platform. The partnership will facilitate establishing a ‘gold standard’ in the advancement of cell therapies.
Ozette announces new partnership with Umoja Biopharma.
Leveraging Ozette’s proprietary immune cell population discovery and annotation platform, Umoja will be working to discover novel oncology insights in preclinical models.
